StockData
Belite Bio, Inc logo

Belite Bio, Inc (BLTE) stock

BLTENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 31, 2026Score 5/30
$157.72−4.84 (-2.98%)

Close on Nov 17, 2026Market cap $6.20BP/E –Yield –

Belite Bio market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Belite Bio's market cap was $6.13B on Nov 11, 2026, against $4.37B a year earlier. Over the last 5 years it ranged from $108.81M to $7.49B, with a median of $1.43B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$6.13B+20.5%
2025Dec 31, 2025$5.09B+176.8%
2024Dec 31, 2024$1.84B+61.5%
2023Dec 29, 2023$1.14B+267.8%
2022Dec 30, 2022$309.72M–

More Belite Bio figures

See a number that looks wrong?